{Reference Type}: Journal Article
{Title}: Radiofrequency Ablation: A Promising Treatment Method for Abdominal Wall Endometriosis.
{Author}: Mahdavi A;Forouzannia SA;Goudarzi E;Forouzannia SM;Rafiei R;Yousefimoghaddam F;Rafiei N;Padmehr R;
{Journal}: Cardiovasc Intervent Radiol
{Volume}: 0
{Issue}: 0
{Year}: 2024 May 29
{Factor}: 2.797
{DOI}: 10.1007/s00270-024-03755-4
{Abstract}: <B>OBJECTIVE: </B>To evaluate the application of radiofrequency ablation (RFA) as a treatment method for abdominal wall endometriosis (AWE).<BR><B>METHODS: </B>The characteristics of the AWE lesions in the patients were obtained using ultrasound (US). The patients received general and local anesthesia, and then, AWE lesions were divided into 1 cm3 sections visually, and each of these sections underwent US-guided RFA using the moving shot technique. Follow-up included outpatient appointments, including a US examination 1, 3, and 6 months after the treatment to assess the volume of the lesions. In addition, the level of pain experienced by the patients was measured using a visual analogue scale (VAS) before and the day after the procedure, as well as at each follow-up appointment.<BR><B>RESULTS: </B>Ten patients were treated with RFA. The procedural success was achieved in all of the patients. The median volume of the lesions decreased from 7.3 cm3 (IQR = 4.39,23.75) to 2.95 cm3 (IQR = 1.65,9.09) (P = 0.005). All patients reported reduced pain levels, and the median of their VAS score decreased from 9 (IQR = 8,9) to 0 (IQR = 0,1.25) (P = 0.004) at the end of the follow-up period. None of the patients experienced complications related to RFA treatment.<BR><B>CONCLUSIONS: </B>Based on the study's findings, RFA appears to be a promising minimally invasive treatment for AWE. However, larger studies with longer follow-up periods are required for a more comprehensive understanding of its efficacy and safety.<BR><B>METHODS: </B>Level 4, Case Series.